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1. Introduction 
End stage renal disease (ESRD) and diabetes mellitus are independently associated with 
advanced atherosclerosis with extended arterial wall calcifications and occlusions in inferior 
limb arteries (Norgreen et al., 2007). A severe arterial affectation was commonly 
documented in critical inferior limb ischemic (CLI) wounds, particularly located in the tibial 
trunks of these patients (Casserly, 2008; Norgreen et al., 2007). The association of CLI in 
subjects with impaired renal function and particularly ESRD leads to a notable higher rate of 
subsequent morbidity and mortality (Andreoli et al., 2008; Casserly, 2008; Mlekusch et al., 
2004). Although revascularization indisputably represents the primary therapy for limb 
salvage (Casserly, 2008; Conrad et al., 2009; Norgreen et al., 2007), renal patients seem to 
require strikingly more challenging interventions, that focus hostile and diffusely diseased 
leg segments (Andreoli et al., 2008; Casserly, 2008; Conrad et al., 2009; Randon et al., 2010). 
Literature on arterial reconstruction (surgical and endovascular) reveals poor patency, tissue 
recovery and limb preservation data, coupled to high short and mid-term mortality rates for 
ESRD subjects (independently from other cardio-vascular risk factors) (Abou-Zamzam et al., 
2007; Bradbury et al., 2010; Casserly, 2008; Leers et al., 1998). Similar observations were 
independently documented in diabetic ischemic limbs that have the metabolic and 
neuropathic background, local sepsis and important amount of tissue loss (Apelqvist et al., 
1993; Dormandy et al., 1999; Edmonds, 2008; Norgreen et al., 2007).  However, despite 
progresses in both surgical and endovascular approaches, in 14%-20% of these patients 
exhibiting advanced crural and pedal occlusive disease, neither of the available procedures 
can provide appropriate distal arterial supply, turning to amputation (Abou-Zamzam et al., 
2007; Dormandy et al., 1999; Faglia et al., 2007). In these desperate cases, since all 
“conventional” arterial revascularization techniques were unsuccessful, the concept of 
“venous arterialization”, as extreme alternative for delivering the oxygenated blood to distal 
ischemic tissues was considered. These limb salvage alternatives for extreme CLI 
presentations (currently intended to amputation) were mostly described as using the 
available superficial veins of the affected limb (Jacop et al., 1999; Lengua et al., 2001).  
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While some reports claim encouraging limb salvage results (Jacop et al., 1999; Lengua et al., 
2001; Lu et al., 2006), others remain reserved (Matzke et al., 1999). 
Parallel efforts in CLI limb preservation were reported in the plastic reconstructive surgery 
field, by promoting the angiosomes model (AM) for reperfusion and tissue reconstruction 
upon specific arterial and venous bundles of blood supply (Attinger et al., 2001, 2006; Taylor 
& Pan, 1998). 
A schematic description of these tissue irrigation areas in the foot is illustrated in Fig. 1.  
 
 
Fig. 1. A simplified illustration of the main angiosomes (and  correspondent venosomes) 
related territories of the foot and ankle:   
MC: The Medial Calcaneal Artery,  
MP: The Medial Plantar Artery and LP:  The Lateral Plantar Artery angiosomes, dependent from 
the Posterior Tibial Artery territory, 
DP:  The Dorsalis Ppedis Artery angiosome,  from the Anterior Tibial  arterial and venous 
bundle,  and LC:  The Lateral Calcaneal Artery  angiosome from the Peroneal arterio-venous tract. 
We propose to examine in this chapter the clinical efficacy of a new hybrid limb salvage 
technique (surgical and endovascular) for deep venous selective arterializations in extreme 
diabetic CLI presentations, unfit for any of the common arterial reconstructive methods 
(Alexandrescu et al., 2011). The method also proposes an appended AM strategy for 
revascularization, in the hope to enhance appropriate wound healing in these challenging 
situations (Alexandrescu et al., 2011; Attinger et al., 2006 Taylor & Pan, 1998). 
2. Material and methods  
Patients. From January 2003 until October 2010, a series of 28 limbs with threatening 
ischemic foot wounds in 26 diabetic and ESRD patients were retrospectively studied. All 
subjects were at high risk for major limb amputation with no feasible conventional arterial 
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revascularizations. They were treated by hybrid (surgical and endovascular) deep calf veins 
arterialization following the AM concept. This method allows Selective Arterio-Venous 
Endoluminal Switch (the SAVES- technique, previously described by our group in the deep 
calf veins (Alexandrescu et al., 2011), following an AM strategy of perfusion (Attinger et al., 
2001, 2006; Taylor & Pan, 1998). Two patients received a staged bilateral intervention at 
eight and twelve months interval, respectively. The method’s aim is to provide a pulsatile 
flow to the foot by selective bypass arterialization of one of the paired either anterior, 
posterior or peroneal deep calf veins (according the AM distribution), with synchronous 
devalvulation and endoluminal coil-exclusion of the collaterals. The group gathered specific 
presentations with unfeasible or previously failed arterial reconstrucions, including lack of 
superficial vein material or inappropriate tissues conditions for distal bypasses (including 
eventual arterializations in the superficial venous network). Severe ischemic wounds 
(Rutherford categories 5-6.) (Dayal & Kent, 2005; Rutherford et al., 1997) confined to the foot 
(Wagner grades 3-4) (Driver et al., 2007) were noted in 22 limbs (79%), whereas 6 (21%) 
others presented complex below the knee trophic lesions. Advanced gangrene with 
irrecoverable tissue loss (Wagner grade 5 lesions) (Driver et al., 2007), preexisting severe 
cardiac insufficiency (LVEF < 30%) and eventual disagreement of patients for this type of 
intervention, represented the major exclusion criteria. 
There were 20 men and the mean age was 73.7 years (in the range 56-89). Nine (32%) cases 
were insulin dependent.  
Patient characteristics and risk factors are summarized in Table I:  
 
 
Table I.  
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The technical features of the 28 combined surgical and endovascular angiosome-oriented 
interventions are described in Table II:  
 
 
Table II.  
All patients were simultaneously followed in the nephrology-dialysis department. They 
underwent a preoperative complete inferior limbs arterial and venous Duplex scan, adding 
either DS-Arteriography (in our early experience) or preliminary Angio-CT assessment 
coupled to a per-operative angiography (in the recent years).  
Complementary Duplex notification concerning the valvular competence and the 
anatomical distribution (the level of vein duplication) concerning the deep venous system 
were collected.  
Following arterialization, adjuvant wound therapy was pursued in a multidisciplinary 
“diabetic-foot” clinic, according to each specific tissue defect presentation / Table III: 
 
 
Table III. 
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Definitions.  Clinical grading of the inferior limb ischemia was evaluated according to the 
revised criteria of SVS/ISCVS (Rutherford et al., 1997) and the TASC (II) recommendations 
(Norgreen et al., 2007). Other specific clinical findings were guided by the Wagner revised 
classification (Driver et al., 2007) and the UK peripheral neuropathy screening score (Young 
et al., 1993).  
The technical success was considered if a direct arterialized axis starting from the iliac level 
through the selected deep calf veins till the peri-malleolar or foot level network was present 
after devalvulation and selective embolizations of venous side branches. This implied lack 
of deep vein narrowing or major steal phenomena, induced by venous tibial collaterals or 
perforators.   
Limb salvage implied no requirement of major amputation and if the functional autonomy 
of the patient was recovered (walking or standing) despite eventually minor amputations (at 
the metatarsal or toe level).  
Endpoints and statistical analysis.  All results were reported in an intention to treat 
analysis. Patency, clinical success, limb salvage and patients survival rates were studied 
using the Kaplan-Meier life-table method at sequential intervals. 
The surgical and endovascular “SAVES” method for deep calf vein arterializations. The 
“hybrid” technique for vascular reconstruction (Selective Arterio-Venous Endoluminal 
Switch - the “SAVES” method) followed a similar protocol, as previously described by our 
team (Alexandrescu et al., 2011). The pre-operative medication included a constant anti-
platelet therapy (160 mg aspirin daily or clopidogrel 75 mg/day). In this cohort, the 
treatment was already started in all patients before the procedure for previous 
miscellaneous cardio-vascular problems. General anaesthesia was applied in 21 cases (75%), 
local anaesthesia and slight sedation in 6 (21%), while sole local anaesthesic products were 
preferred in 1 (4%) of interventions. In the first stage of the procedures (surgical), a classical 
protocol for femoro-infragenicular PTFE bypass was undertaken (Fig. 2 and 3b).  
 
 
Fig. 2. Distal  “PTFE- graft” anastomosis at the popliteal level: 
a. The presence of a “twin popliteal veins” anatomical pattern white arrows), 
b. Termino-lateral anastomosis as to arterialize one of the two popliteal veins in a femoro 
(arterial) – popliteal (venous) PTFE graft during the first stage of the procedure. The synthetic 
graft allows the passage of a long 6F introducer from the groin, further enhancing the second 
stage of the intervention: selective devalvulation and collateral embolization of specific tibial 
deep veins, following the AM distribution. 
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Fig. 3. a) A brief illustration of the main deep venous trunks in the leg:  
PFv:  Profound  Femoral vein,  
SFv:  Superficial Femoral vein, 
Popl. vv:  Popliteal veins, 
AT. vv:  Anterior Tibial veins  
Peron. vv:  Peroneal veins  
PT. vv:  Posterior Tibial veins                     
b) The red curved arrow: schematic arterial in-flow from the groin. Below the knee twin veins 
and their correspondent venosomes: 
In red: appended  Anterior Tibial  Venosome, 
In yellow:  correspondent  Peroneal  Venosome, 
In blue: adjacent Posterior Tibial  Venosome. 
The common femoral artery was usually the chosen in-flow vessel (n= 16) albeit the SFA (n= 
7) and the popliteal artery (n= 5) was seldom employed. The location of the distal 
anastomosis, to induce direct arterial flow toward the deep calf veins (Fig. 2), was planned 
upon the Duplex findings on the level of duplication (Table II) and topographical 
specificities of the wounds (the angiosomes distribution) (Attinger et al., 2001, 2006; Taylor 
et al., 1990, 1998). This distal anastomosis was realised on one of the doubled deep veins in a 
termino-lateral (n = 23) (Fig. 2) or termino-terminal way (n = 5). In all the cases, 8mm PTFE 
armed prosthesis (n = 21/ Distaflow BARD co. USA, and n = 7/ GORE Medical Products 
co.USA) were placed. Before clamping the femoral artery, a 2500 IU heparin amount was 
given in order to promote anticoagulation yet, minimizing possible interferences with the 
second procedural stage (endovascular), the collateral embolizations. The cephalad segment of 
the twin vein was ligated, while side anastomosis was chosen. Although the distal popliteal 
vein was found more often paired than single (Fig. 2 and 3) according to other similar 
observations (Wind et al., 1991), in ten cases (35%) the distal anastomosis was performed 
directly in selected venous tibial trunks (Table II.) and oriented toward the main 
corresponding foot angiosome (venosome) (Fig. 1 and 3). After releasing the flow in the 
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PTFE arterio-venous bypass, an 80cm / 6-F introducer sheath (Cook, inc. UK) was 
antegradely mounted via the common femoral artery traversing the prosthetic graft. A road-
mapping of the infra-popliteal venous deep network was obtained, beyond the distal 
anastomosis. The competence of the deep valvular system was documented (often already 
affected by neuropathic “idiosyncratic deep venous distension” in this subset of patients) 
(Pureval et al., 1995). Although rarely needed, devalvulation was initially started by 
crossing each valve with a 0.035-inch hydrophilic guidewire (Terumo, Japan) and 
accomplished by the passage of the 6-F 80 cm long introducer sheath (occasionally 
necessitating few “back and forth” co-axially over the wire movements) (Fig. 4a and 5a).  
 
 
Fig. 4. Specific Anterior Tibial deep veins arterialization:  
a. Initial selective embolization of the Posteriof Tibial and twin veins with peculiar 
canulation of the Anterior Tibial vein, enabling to direct the arterialization toward the 
Anterior Tibial angiosome and correspondent venosome. 
b. Specific catheterization and devalvulation of the Anterior Tibial vein tovard the ankle, 
c. The newly induced arterial flow in the Anterior Tibial venosome, after specific collateral 
embolization. 
d. The initial clinical presentation featuring an extended ischemic and infected ulcer on the 
anterior tibial aspect of the calf. 
e. The clinical outcome following specific anterior tibial veins arterialization, at seven 
months after multidisciplinary follow-up.  
The long sheath was advanced until the ankle region in the angiosome-selected venous 
pathway. Contrast mapping demonstrated the principal collaterals or perforators of the 
chosen deep vein axis. Using a floppy tip 5-F vertebral or “Cobra 2-3” catheters (Cook inc., 
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UK) or, in some other instances with a better adapted 4-F curved hydrophilic micro-catheter 
("Slip-cath" selective catheter, Cook inc. UK), the main venous collaterals were selectively 
catheterized and occluded using coils embolization material (5-F “Tornado”,  “Nester” or 
stainless steel 5-8mm coils /Cook inc., Medical UK) (Fig. 4 a, b, c, and 5 a, b). These coils 
were delivered mainly using the “coaxial” technique (and seldom only by the “anchor” 
method) (White & Pollak, 2006) in the principal deep venous ramifications. There was an 
average of 7.1 (n= 5-19) coils released per procedure. The side branches embolization 
stage was performed as distally as possible (Fig. 4c and 5c), toward the clinical venosome-
location of the wounds (White & Pollak, 2006). The progressing results were assessed by 
small contrast injections (Fig. 4c and 5c). Not all the collaterals were approachable during 
this stage of the procedure, particularly the medium-sized to small diameter veins, 
usually located in the peri-malleolar deep network (Fig. 5c). To avoid prolonged time and 
contrast consuming interventions, the selective branch embolizations were restricted 
below the ankle level, as the distal blood pressure measured through the 6-F introducer 
sheath edge exceeded 50 mm Hg. This observation allowed exclusion of residual CLI 
hemodynamic features (Norgreen et al., 2007; Rutherford et al., 1997). Hemostasis was 
directly performed at the arterial puncture level after the withdrawal of sheaths. All 
patients were prescribed aspirin (160 mg/day) after the procedure, unless intolerant or 
previous treatment with clopidogrel, ticlopidin or oral anticoagulation, in which case 
these last ones were prolonged.  
 
 
Fig. 5. Deep Posterior Tibial veins selective arterialization:  
a. Devalvulation in the main vein trunk using the 0.035-inch guidewire and the passage of 
the 6F long introducer sheath. 
b. Selective “coaxial” embolization of the main deep vein collaterals owing a 5F curved 
microcatheter. 
c. Regain of the arterial flow in the vein collaterals around the heel targeting the medial 
calcaneal angiosome  (and its appended venosome). 
d. The initial heel neuro-ischemic wound. 
e. Clinical result at five months providing the same multidisciplinary “diabetic foot” team 
surveillance. 
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Follow-up. In the post-operative period, patients were assessed by periodical clinical and 
hemodynamic (duplex scan) evaluations, focusing on tissue healing, bypass patency and the 
presence of arterial waves in the ankle or foot deep veins. Information was collected one 
month after discharge and every 6 months thereafter. In cases showing clinical tissue 
deterioration as primary end-point, corroborated by corresponding duplex findings, further 
Angio-CT or MRI evaluation was undertaken. Mean follow-up was 23.3 months (in the 
range 1-68 months). 
3. Results 
The initial technical success was achieved in 21/28 limbs (75%) with 96% corresponding 
thirty-day peri-operative mortality rate (one patient died from myocardial infarction). In 
seven instances, the procedure could not follow the scheduled protocol. In 2 cases, the distal 
venous anastomosis of the PTFE graft was unachievable either in a context of extensive 
fibrosis (multiple previous interventions) or by substantial inflammation. In 2 others, 
unexpected wall laceration of the selected venous conduit during the devalvulation stage 
required hemostasis by direct embolization of these veins. Since alternative deep veins 
arterializations without AM guidance were used, these cases were categorized as technical 
failures. There were 3 other situations when the distal embolization of collaterals could not 
be achieved: in two limbs, a rich network of fine branches with sharp angle and retrograde 
emergence rendered difficult all endovascular manoeuvres, while in other case the 
embolization stage was discontinued following an intolerance to contrast agents. For the 
whole 7 technical failures, 4 compulsory arterializations (non angiosomes-oriented) of 
miscellaneous deep or superficial veins, one minor and 2 major amputations were 
requested. During the first year of follow-up, there were 2 graft occlusions. In both 
instances, irregularities in the postoperative medication (modest compliance of patients) 
were noted. After eight months of surveillance one of these 2 limbs showed however, a 
correct tissue recovery despite the PTFE thrombosis, while major amputation was inevitable 
for the other.  
The cumulative primary and secondary patency were (+/-SEM): 71% (+/- 9%), 59% (+/- 
10%) and 59% (+/- 10%), at 12, 24 and 36 months, respectively. Limb salvage showed: 86% 
(+/- 7%) at one year and steady 77% (+/- 10%) afterwards, while the clinical success was: 
82% (+/- 7%), 71% (+/- 10%) and 71% (+/- 10%) at identical time intervals (Fig. 6).  
Deep venous system reflux was assessed in 19/28 (68%) limbs, whereas in only 10/28 (35%) 
previous evidence for clinical venous insufficiency was available. In all 28 treated limbs 
deep vein duplications were documented (preoperative Duplex) as follows: 20 in the distal 
popliteal (71%) (Fig. 2), 5 in the proximal popliteal (18%) and 3 concerning the superficial 
femoral (12%) deep veins. The overall 30-day peri-operative complication rate was 21% 
(6/28cases). Major complications were noted in three cases (11%): there were two temporary 
cardiac deficiencies after the initiation of the arterio-venous flow compensated by inotropic 
agents and diligent medical treatment and one secondary compartmental syndrome coupled 
to venous gangrene, ending in inevitable amputation. There were 3 other minor 
complication represented by 2 venous branch perforations of the collaterals with self 
limiting local effects and one causing secondary limb swelling, that needed prolonged 
postoperative physiotherapy before ambulation. Following the evoked AM strategy and 
appended venosome-model for arterialization (Fig. 1), we have noted: 10 limbs treated by 
preferential anterior tibial veins arterialization (trophic lesions located on the anterior leg 
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and ankle, the forefoot, dorsum of the toes and foot) (Fig. 4), 16 others having 
revascularizations in the posterior tibial veins territory (ulcers of the medial calcaneal, 
plantar, hallux, medial malleolar and Achillean teguments) (Fig. 5), while the remnant 2 
targeted a dominant peroneal in-flow (wounds located in the lateral calcaneal and lateral 
malleolar territories) (Table II.).  
 
 
Fig. 6. Patency, Limb Salvage and Clinical Success statistical data.  
Although complete healing with or without minor amputations was documented in 15 
treated limbs (54%) (Fig. 4e and 5e), notable trends for tissue recovery without complete 
cicatrization were observed in 7 others (25%). Major amputations were however, inevitable 
in the remnant 6 presentations (21%). Cyclic relapses of the wounds, albeit without ischemic 
Duplex features were documented in 11 (39%) cases, mostly between the 10th -15th months of 
follow-up. These limbs were invariably associated a severe neuropathic background. 
In the whole group of patients, six (21%) major amputations for miscellaneous clinical 
reasons were documented (2 technical failures, 2 major complications, 1bypass thrombosis 
and 1 progressively irreversible forefoot sepsis). 
The thirty-day peri-operative mortality rate was 0%. The cumulative survival rates were 
93%, 66% and 38% at 12, 24 and 36 months, respectively.    
4. Discussion  
The renal patient presents with unanimously recognized severe CLI features and consequent 
difficult revascularization patterns (Casserly, 2008; Conrad et al., 2009; Leers et al., 1998; 
Norgreen et al., 2007). A vast amount of contemporary literature shows the poor outcome 
commonly noted after surgical or endovascular arterial reconstruction in these patients 
(Arvela et al., 2010; Black et al., 2005; Casserly, 2008; Conrad et al., 2009; Leers et al., 1998). As 
the revascularization seems however feasible, particularly aggressive atherosclerosis coupled 
to long segment chronic occlusions, calcifications and depleted run-off, make further arterial 
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patency and limb preservation quite questionable in ESRD subjects (Arvela et al., 2010; Black et 
al., 2005; Casserly, 2008; Leers et al., 1998). These poor clinical results are often associated with 
a high co-morbidity and mortality, independently from diabetes and other cardio-vascular risk 
factors (Leers et al., 1998; Mlekusch et al., 2004; Norgreen et al., 2007). Similar observations 
were described in the diabetic CLI context that adds the metabolic and neuropathic 
background, local sepsis, poor immune response and variable amounts of foot tissue loss 
(Abou-Zamzam et al., 2007; Apelqvist et al., 1993; Norgreen et al., 2007).    
Moreover, the diabetic CLI “macro-angiopathic” atherosclerosis is characterised by enhance 
more aggressive and more distal occlusive lesions, with preferential tropism in the tibial 
trunks (Apelqvist et al., 1993; Dormandy et al., 1999; Faglia et al., 2007 Norgreen et al., 2007). 
A synchronous functional microcirculatory affectation induced by both neuropathic and 
septic entanglement, was also witnessed in this multifaceted pathology of the diabetic foot 
(Apelqvist et al., 1993; Boulton et al., 2006; Edmonds, 2008). Despite soaring progresses in 
technology and aggressive follow-up, long-term limb preservation seems however inferior 
in diabetic – ESRD subjects compared to other CLI patients, mainly due to extended 
infragenicular arterial thrombosis, calcifications and poor distal foot runoff (Abularrage et 
al., 2010; Dormandy et al., 1999).   
While non-diabetic subjects seem to express intima-layer, eccentric and patchy wall arterial 
calcifications, prevailing in the coronary also the peripheral vessels (the « type I » 
calcifications) (Irvin & Guzman, 2009), the diabetic also ESRD patients have media-layer, 
concentric and rather continuous wall calcifications (the “Mönckeberg sclerosis” or « type 
II » calcifications) (Irvin & Guzman, 2009). These particularly dense « type II » calcific 
deposits featuring the below-knee arterial trunks were independently associated with more 
severe CLI presentations (Irvin & Guzman, 2009 ; Leskinen et al., 2002), requiring additional 
technical challenges (Abou-Zamzam et al., 2007; Alexandrescu et al., 2011; Casserly, 2008; 
Leers et al., 1998) and consequent higher technical failures. They were also connected with 
low patency and discouraging limb loss rates (Casserly, 2008; Combe et al., 2009; Leers et al., 
1998; Ohtake et al., 2011). 
The reported 1-year survival rate after major amputations ranges between 50%-60% and 
seems to be worse for patients undergoing above- the-knee versus below-the-knee 
interventions (Dormandy et al., 1999; Toursarkissian et al., 2002). Despite undeniable 
progresses in both surgical and endovascular approaches, in about 14%-20% of patients 
featuring severe crural and pedal occlusive disease, neither of the available techniques can 
afford appropriate distal arterial supply, resulting amputation (Abou-Zamzam et al., 2007; 
Apelqvist et al., 1993; Combe et al., 2009 Norgreen et al., 2007; Toursarkissian et al., 2002). 
This assertion seems particularly valid regarding the ESRD subjects suffering from CLI 
(Abou-Zamzam et al., 2007; Apelqvist et al., 1993; Arvela et al., 2010; Black et al., 2005; 
Casserly, 2008; Conrad et al., 2009). 
Complementary efforts for limb preservation were achieved in the plastic reconstructive 
surgery field, by applying the AM policy for perfusion in tissue rebuilding. The concept 
delineates the human body in specific 3D blocks of tissue, fed by peculiar arterial and 
venous bundles of blood supply (Attinger et al., 2001, 2006; Taylor et al., 1990, 1998). 
Originally pioneered for the pediculated flaps techniques, the AM strategy (Attinger et al., 
2006; Taylor et al., 1998) was also applied to improve healing in lower limb ischemic ulcers 
(Alexandrescu et al., 2008; Neville et al., 2009; Varela et al., 2010; Setacci et al., 2010). Based 
on the anatomical studies of Taylor (Taylor et al., 1990, 1998) and Attinger (Attinger et al., 
2001, 2006), new preferential strategies for vascular access, revascularization or amputation 
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were described. Schematically, in the foot and lower ankle were initially allocated 5 
angiosomes (Attinger et al., 2006; Taylor et al., 1998) depending on the three main tibial 
trunks : the anterior, the posterior tibial and the peroneal arteries. A succinct exemplification 
of the corresponding skin sectors is showed in Fig. 1. Each angiosome encompasses an 
arterial (arteriosome) and correspondent venous (venosome) participation (Taylor et al., 
1990, 1998). Particularly for this chapter, a specific venosome-orientation (concerning the 
venous facet of each angiosome) (Alexandrescu et al., 2011; Taylor et al., 1990) in deep calf 
veins arterialization was designed (Fig. 3b).  
Deep veins arterialization in ESRD and diabetic CLI patients may offer the advantage to 
direct flow in the deep calf venous conduits spared from typical type II calcifications (Irvin & 
Guzman, 2009) and extended chronic occlusions (Lu et al., 2006; Toursarkissian et al., 2002). 
This may enable to deliberately choose specific distal territories (Fig. 4 and 5) to be reperfused 
(Alexandrescu et al., 2011). It may also fit selected extreme situations for limb salvage, 
despite irrecoverable occlusions of the arterial network (Alexandrescu et al., 2011; Lu et al., 
2006). The concept of venous arterialization to treat advanced CLI presentations has 
emerged as an extreme therapeutic alternative in cases with impracticable conventional 
arterial reconstructions (Jacop et al., 1999; Lu et al., 2006). In Table I, are schematized the 
main features of the patients addressed for this technique. The majority of arterializations 
for “hopeless” CLI presentations intended for amputation were described in the literature 
using the available superficial venous system (Jacop et al., 1999; Lengua et al., 2001; Lu et al., 
2006). A growing number of contemporary reports seem to provide rather encouraging 
(Lengua et al., 2001; Lu et al., 2006) than pessimistic results (Matzke et al., 1999) concerning 
this evolving technique. In most of the published studies, the arterialized venous conduit 
and the distal anastomosis are located at different levels in the superficial saphenous 
system, usually adding destruction of the appended valves (Lengua et al., 2001; Lu et al., 
2006; Ozbek et al., 2005). In this setting, the arterialization of the superficial venous network 
carries however, some possible limitations: a) its availability (particularly in ESRD, diabetic 
CLI patients with huge dialysis-access and cardio-vascular surgical past) and b) the presence 
of surrounding inflammation, sepsis and edema. This latest factor affects the “quality” of the 
surounding venous bed and hampers further graft preparation or its accessibility to the 
distal foot anastomosis (Alexandrescu et al., 2011; Lu et al., 2006). Furthermore, in these 
situations the eventual affiliation of the AM concept may be problematic, as the saphenous 
network offers only limited choices in targeting specific areas for foot arterializations 
(Alexandrescu et al., 2011). Only odd reports are focusing until yet, on alternative deep 
veins arterialization for CLI limb salvage. This strategy was however previously proposed, 
either in experimental (Ozek et al. 1997) or as staged interventions (Chen et al., 1998; Lu et 
al., 2006), without systematic valvular avulsion.  
Although rational, the genuine concept for distal valves destruction in newly arterializated 
venous conduits, has give rise to different techniques assembling either metallic olives, 
retrograde balloon PTA or 0.035-inc guidewire-enhanced valvular disruption, sustained or 
not by Fogarty catheters (Lu et al., 2006). Other authors have promoted the sole hydraulic 
effect of the new arterial pulsatile flow, as to be adequate enough for counteracting the 
venous valves barrier, especially in the deep venous circulation (Chen et al., 1998; Krisnan & 
Rayman, 2008; Lu et al., 2006). In spite of recent supportive observations (44), this latest 
hypothesis remains controversial (Lu et al., 2006). 
In the author’s group experience, we stressed the concept of restoring limb perfusion in the 
deep venous pathway, for untreatable ESRD ischemic lesions deemed for “classical” arterial 
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reconstructions. Most of these cases featured characteristic infrapopliteal extensive 
occlusions (Casserly, 2008; Conrad et al., 2009; Norgreen et al., 2007; Toursarkissian et al., 
2002) and calcifications (Alexandrescu, 2009; Irvin & Guzman, 2009; Krisnan & Rayman, 
2008; Leskinen et al., 2002), when all types of conventional reconstructions have previously 
failed or were impracticable (Table I.).  
In this setting, bypassing the deep venous network towards the distal foot circulation 
seemed unconditioned neither by tegumental integrity, swelling or tissue infection, nor by 
the availability of saphenous versus other autologous bypass conduits. The current calf 
venous duplication (Wind et al., 1991), may offer the possibility to enhance precise 
arterializations (Fig. 3-5) in one of the twin tibial veins (Alexandrescu et al., 2011), by 
following a specific AM strategy (Alexandrescu et al., 2011; Taylor et al., 1990). To achieve 
this aim, acquiring effective valvular incompetence also proved to be indispensable in our 
experience. This was either primary induced by the first crossing of the 0.035-inch 
hydrophillic guidewire (Fig. 5), or complementary obtained with the passage of a 6-F, 80 cm 
long introducer sheath through the distal deep vein (Fig. 4b and 5b). Nevertheless, the lack 
of residual valvular tensile stress was documented in all the cases by injecting a small 
amount of contrast before proceeding to the embolization stage. A preexistent valvular 
incompetence by vein walls enlargement was witnessed in more than 25% of cases, 
oftentimes without previous evidence for chronic venous insufficiency. This finding may 
correlate the presence of up to 93% neuropathic limbs in this cohort (Table I.), that exhibit 
the previously described “idiosyncratic deep venous distension” context (Alexandrescu et al., 
2011; Boulton et al., 2006; Edmonds, 2008; Pureval et al., 1995). The existence of neuropathy-
associated capillary shunting in diabetic ESRD subjects (Krisnan & Rayman, 2008; Pureval et 
al., 1995), seems to allow local redistribution of the dermal, sub-dermal and muscular blood 
flow and by additional ascendant venous collectors (Calota et al., 2007). This makes possible 
the blood mass transfer from deep calf to the surface, especially as moderate venous 
hypertension appears (Calota et al., 2007; Edmonds, 2008; Krisnan & Rayman, 2008). 
Duplication in tibial veins may allow the arterialized flow to be deliberately oriented 
towards specific ulcerated zones of the distal leg (Alexandrescu et al., 2011; Taylor et al., 
1990) according to the AM policy (Fig. 1 and 2). First described by Taylor et al. (Taylor et al., 
1990, 1998), the “angiosomes model” for perfusion was further developed by Attinger et al. 
(Attinger et al., 2001, 2006) also in the plastic reconstructive surgery field. Although with 
limited contemporary evidence for CLI applications at the present time, this concept seems 
to gain more acceptance in the limb salvage domain (Neville et al., 2009; Varela et al., 2010; 
Setacci et al., 2010) and represents one of the current concerns of our multidisciplinary 
diabetic "foot-team" (Alexandrescu et al., 2008, 2009, 2011). According to their initial 
description, each angiosome encompasses twin arteriosomes and venosomes for blood supply, 
all being interconnected in a vast compensatory system (the”choke vessels”) (Attinger et al., 
2006; Taylor et al., 1998). The arterial side of this “rescue network” relying on adjacent 
angiosomes seems particularly damaged in ESRD/diabetic patients exhibiting peculiar 
medium-sized collaterals depletion by aggressive atherosclerosis joined to small arterial 
septic thrombosis (the already reported “end artery occlusive disease” pattern) (O’Neal, 2008). 
Unlike the arteries, deep calf veins and collaterals seem less affected by this occlusive 
process (Alexandrescu et al., 2011; Krisnan & Rayman, 2008). This important aspect may 
enable deep vein arterialization to access specific leg territories (angiosomes), throughout 
their appended venous communicants (venosomes), in areas although deprived from direct 
arterial connections (Alexandrescu et al., 2011).   
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We used the venosomes orientation (Taylor et al., 1990) joined to the SAVES technique 
(Alexandrescu et al., 2011) in all these marginal candidates for common revascularizations 
and observed correct healing with or without minor amputations in 15 treated limbs (54%). 
Notable trends for tissue recovery however without complete cicatrization were 
documented in 7 others (25%). Major amputation were inevitable in the remnant 6 
presentations (21%).  
It has been stipulated that the “venosomes” allocation may be prone to anatomical 
variations (Taylor et al., 1990) according to the individual distribution of the deep venous 
system (Calota et al., 2007; Taylor et al., 1990; Wind et al., 1991) (Fig. 3). We believe that 
systematic preoperative Duplex assessment joining « on table » road-mapping, may provide 
important information in detecting these venous pecularities (26% limbs in our cohort). We 
also observed that staged embolizations of the major vein collaterals were technically more 
demanding in the posterior tibial territory (Fig. 5), by steady large perforators or 
communicants, sometimes appointing sharp retrograde emergences with more arduous 
cannulation. 
All treated patients expressed discrete to moderate lower limb edemas after arterializations. 
This phenomenon showed generally a spontaneous resolution during the postoperative first 
month. Similar observations in dedicated literature suggest that the more distal the location 
of the outflow anastomosis in long arterio-venous fistulas (femoro-infrapopliteal in our 
technique), the higher likelihood to enhance a better cardiac tolerance (Lengua et al., 2001; 
Ozek et al. 1997).  
As noticed, in one case (4%) persistent limb swelling joining calf compartmental syndrome 
and venous gangrene were documented, unfortunately ending with major amputation.  
In two other cases (8%), cardiac insufficiency symptoms were perceived: one precocious  
and reversible manifestation (in the 30-day complications subset) and one insidious and 
retarded presentation (two months after the procedure), in a severe and inoperable coronary 
context.  
The study presented in this chapter may express some clear limitations: beyond its 
retrospective nature and the small number of cases included, the results in terms of limb 
salvage are not easy to be compared with other series of conventional arterial 
reconstructions or venous arterializations, since the technique itself and the selection criteria 
are different. 
In addition, the “SAVES” method represent only an evolving therapeutic option, since 
specific difficulties and related complications (notably the collateral embolization stage), 
may be subject for further technical improvements. A larger clinical experience and skills, 
joining more sophisticated devices for endovascular navigation and collateral occlusion (like 
modular micro-catheters, specific pro-thrombotic substances or embolic microspheres) may 
probably contribute to further technical refinements. Finally, to accurately evaluate and 
compare limb preservation in this subset of diabetic and renal patients oftentimes implies 
(beyond reestablishing limb perfusion) the undeniable implication of multi-disciplinary 
team surveillance (Abularrage et al., 2010; Alexandrescu et al., 2008; Apelqvist et al., 1993; 
Boulton et al., 2006; Driver et al., 2007; Edmonds, 2008; Norgreen et al.). 
5. Conclusion 
Deep calf venous arterialization (the SAVES-method) may represent an extreme alternative 
for limb salvage in selected, inoperable presentations for conventional arterial 
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revascularization. The association of an angiosome strategy seems, at this stage of the 
available clinical experience, a possible useful method to enhance distal ulcer healing. 
Larger studies, providing comparative and randomized data are thus needed, as to ascertain 
these preliminary observations.  
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